You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Fontan-associated liver disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fontan Associated Liver Disease and Evaluation of Biomarkers for

Recruiting
  • Congenital Heart Disease
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Aug 17, 2022

    Cirrhosis, Congenital Heart Disease Trial in Rochester (Sildenafil, Placebo)

    Completed
    Has Results
    • Cirrhosis
    • Congenital Heart Disease
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jul 28, 2021

    Liver Disease, Myocardial Fibrosis and Collaterals in Adult

    Not yet recruiting
    • Patient Participation
    • +4 more
      • (no location specified)
      Mar 22, 2022

      Fatty Liver, Nonalcoholic Trial (SGLT2 inhibitor)

      Not yet recruiting
      • Fatty Liver, Nonalcoholic
      • SGLT2 inhibitor
      • (no location specified)
      Oct 31, 2023

      Evaluation of Fontan-Associated Liver Disease

      Active, not recruiting
      • Single Ventricle Heart Disease
      • Aurora, Colorado
      • +16 more
      Nov 22, 2020

      Betweenq MAFLD and Chronic Kidney Disease

      Not yet recruiting
      • Mafld in Ckd Patients
        • (no location specified)
        Nov 12, 2023

        Metabolic Associated Fatty Liver Disease Trial in Mexico (LUDLEV®300 mg/46.2 mg, Placebo)

        Recruiting
        • Metabolic Associated Fatty Liver Disease
        • LUDLEV®300 mg/46.2 mg
        • Placebo
        • Mexico, Veracruz, Mexico
          Ana Delfina Cano Contreras
        Jun 12, 2023

        Metabolic Associated Fatty Liver Disease and Biopsy Proved Cases

        Recruiting
        • Assessment of Patients With Biopsy Proven Primary Glomerulonephritis Above 18 Years of Age for MFLD Development
          • Asyut, Egypt
          • +1 more
          Nov 27, 2023

          hsCAR and MAFLD: A Cross-sectional Study

          Recruiting
          • Metabolic Dysfunction-associated Fatty Liver Disease
          • +2 more
          • high-sensitivity C-reactive protein to albumin ratio
          • Chongqing, Chongqing, China
            The Second Affiliated Hospital of Chongqing Medical University
          Aug 2, 2023

          Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD), Metabolic Associated-dysfunction Steatohepatitis (MASH) Trial

          Enrolling by invitation
          • Metabolic Associated-dysfunction Steatotic Liver Disease (MASLD)
          • Metabolic Associated-dysfunction Steatohepatitis (MASH)
          • Standard of care acceptance-based behavioral weight loss program
          • Occupational therapy dietary and lifestyle modifications
          • Wyoming, Michigan
            Gastroenterology Associates of Western Michigan, PLC
          Nov 2, 2023

          Metabolic Associated Fatty Liver Disease in Chinese Population

          Completed
          • Metabolic-dysfunction-associated Fatty Liver Disease (MAFLD)
            • Beijing, Beijing, China
              Chinese PLA General Hospital
            Nov 13, 2022

            NAFLD Cirrhosis Trial in New Delhi (Dapagliflozin, Standard of Care)

            Not yet recruiting
            • NAFLD Cirrhosis
            • New Delhi, Delhi, India
              Institute of Liver & Biliary Sciences
            May 5, 2023

            HIV, Non-Alcoholic Fatty Liver Disease, Metabolic-Associated Steatotic Liver Disease Trial in Nashville (Prebiotic, Probiotic)

            Not yet recruiting
            • HIV
            • +2 more
            • Prebiotic
            • Probiotic
            • Nashville, Tennessee
              Vanderbilt University Medical Center
            Oct 30, 2023

            Liver Fat and Glucagon Resistance

            Not yet recruiting
            • Steatosis of Liver
            • Acute glucagon infusion
            • (no location specified)
            Nov 22, 2023

            Fatty Liver Disease, Fatty Liver Trial in Giza (Itopride, conventional therapy)

            Recruiting
            • Fatty Liver Disease
            • Fatty Liver
            • Giza, Egypt
              Maha Youssif Fekry
            Jul 28, 2023

            Carnitine-Orotate Complex and Biphenyl Dimethyl Dicarboxylate in

            Recruiting
            • Metabolic-associated Fatty Liver Disease (MAFLD)
              • Esik, Almaty Region, Kazakhstan
              • +6 more
              Oct 3, 2023

              Intestinal Failure Associated Liver Disease Trial (NST-6179 Part A, NST-6179 Part B, Matched Placebo)

              Not yet recruiting
              • Intestinal Failure Associated Liver Disease
              • NST-6179 Part A
              • +2 more
              • (no location specified)
              Jun 23, 2023

              Pancreatic Exocrine Insufficieny in Metabolic Associated Fatty

              Not yet recruiting
              • Pancreatic Exocrine Insufficiency
              • FECAL ELASTASE
              • (no location specified)
              Mar 27, 2023

              Fatty Liver Trial in Naples

              Completed
              • Fatty Liver
                • Naples, Italy
                  University of Campania Luigi Vanvitelli
                Mar 27, 2023

                CHronic Hepatopathies Associated With ALcohol Consumption aNd

                Not yet recruiting
                • Non-Alcoholic Fatty Liver Disease
                • +4 more
                • Liver biopsy
                • (no location specified)
                Nov 12, 2022

                SARS-CoV-2 Vaccine in Metabolism-related Fatty Liver Disease

                Not yet recruiting
                • Metabolic Associated Fatty Liver Disease
                • Recombinant protein vaccine and adenovirus vector vaccine
                • (no location specified)
                Feb 12, 2023

                Fatty Liver Disease Trial in Cheras (Intermittent Fasting)

                Recruiting
                • Fatty Liver Disease
                • Intermittent Fasting
                • Cheras, Kuala Lumpur, Malaysia
                  Hospital Canselor Tuanku Muhriz
                May 19, 2023

                Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)

                Recruiting
                • Fatty Liver Disease
                • Fibrotouch
                • Beijing, Bejing, China
                  Bejing Tsinghua Chang Gung Hospital
                Jun 13, 2022

                Fatty Liver Disease, Obesity, Liver Fat Trial in Istanbul (Diet, Cornus mas L.(Cornelian Cherry))

                Completed
                • Fatty Liver Disease
                • +2 more
                • Diet
                • Cornus mas L.(Cornelian Cherry)
                • Istanbul, Avcılar, Turkey
                  Istanbul Gelisim University
                Sep 16, 2022

                Disparities Among Liver Transplant Patients

                Not yet recruiting
                • End Stage Liver DIsease
                  • Phoenix, Arizona
                    Mayo Clinic Arizona
                  Aug 1, 2023